New Insights into the Role of CCL17 in Inflammatory Cardiovascular Diseases

New Insights into the Role of CCL17 in Inflammatory Cardiovascular Diseases

In a breakthrough study led by researchers Christian Weber and Yvonne Döring from LMU, exciting new mechanisms have been uncovered that contribute to the development of inflammatory cardiovascular diseases. The main focus of the study was on atherosclerosis, a chronic inflammatory disease of the inner walls of blood vessels that is responsible for a variety of cardiovascular conditions.

Previously, it was known that dendritic cells, which are responsible for recognizing foreign substances in the body and initiating immune responses, produce a signaling protein called CCL17. This protein has been found to influence the activity and mobility of T cells, which are essential in identifying and eliminating infected cells in the body. However, elevated levels of CCL17 in individuals with cardiovascular diseases have been associated with increased risk of atherosclerosis and other inflammatory diseases.

The research team discovered that CCL17 acts through an alternative receptor pathway, distinct from the previously known receptor, to suppress regulatory T cells. These suppressive T cells play a crucial role in tackling vascular inflammations. By targeting and inhibiting specific receptors in this signaling pathway, the researchers were able to demonstrate the significant role it plays in the negative effects of CCL17.

The findings from this study shed new light on the intricate mechanisms involved in inflammatory cardiovascular diseases and provide an important foundation for potential therapeutic interventions. Professor Weber emphasized the impact of this discovery, stating that it represents a major advancement in understanding chronic inflammatory diseases.

By identifying this alternative signaling pathway and elucidating its role in suppressing regulatory T cells, the researchers have opened up new possibilities for targeted interventions and treatments for cardiovascular diseases. This study not only deepens our understanding of atherosclerosis but also highlights the potential for novel therapeutic strategies that could significantly improve the lives of individuals affected by these conditions.

Reference:

Döring, Y., et al. (2024). Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis. Nature Cardiovascular Research. doi.org/10.1038/s44161-023-00413-9.

FAQ section:

What is the main focus of the study?
The main focus of the study is on atherosclerosis, a chronic inflammatory disease of the inner walls of blood vessels that is responsible for various cardiovascular conditions.

What is CCL17?
CCL17 is a signaling protein produced by dendritic cells, which are responsible for recognizing foreign substances in the body and initiating immune responses.

What role does CCL17 play in cardiovascular diseases?
Elevated levels of CCL17 in individuals with cardiovascular diseases have been associated with an increased risk of atherosclerosis and other inflammatory diseases.

What did the research team discover?
The research team discovered that CCL17 acts through an alternative receptor pathway, distinct from the previously known receptor, to suppress regulatory T cells, which play a crucial role in tackling vascular inflammations.

What is the significance of this discovery?
This discovery sheds new light on the mechanisms involved in inflammatory cardiovascular diseases and provides a foundation for potential therapeutic interventions. It represents a major advancement in understanding chronic inflammatory diseases.

How can this discovery lead to treatments for cardiovascular diseases?
By identifying the alternative signaling pathway and understanding its role in suppressing regulatory T cells, the researchers have opened up new possibilities for targeted interventions and treatments for cardiovascular diseases.

Are there any related links?
Unfortunately, the given article does not provide any related links.

Definition of key terms:

1. Atherosclerosis: A chronic inflammatory disease of the inner walls of blood vessels, characterized by the buildup of plaques, which can restrict blood flow and lead to various cardiovascular conditions.

2. Dendritic cells: Cells of the immune system that are responsible for recognizing foreign substances in the body and initiating immune responses.

3. CCL17: A signaling protein produced by dendritic cells, which influences the activity and mobility of T cells.

4. T cells: Immune cells that play a crucial role in identifying and eliminating infected cells in the body.

Suggested related links:

1. Nature Cardiovascular Research
2. Atherosclerosis at PubMed

All Rights Reserved 2021
| .
Privacy policy
Contact